CDEK
← All organizations

Matrix Pharmaceutical

For profit

Also known as: MATRIX MEDCL

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

May 1, 1995

First marketed drug

Jul 24, 1986

Last known activity

Nov 1, 2000

Acquired by Chiron → Novartis on Feb 19, 2002

Timeline

1980s

  1. Jun 1, 1985

    Matrix Pharmaceutical— Founded

  2. Jul 24, 1986

    chlorhexidine— Marketing Organization

2000s

  1. Feb 19, 2002

    Chiron— Acquired By

  2. Jan 1, 2006

    Novartis— Now

Drugs by trial phase (3 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (5)

Details

Founded
Fremont, CA, US Jun 1, 1985
Last known activity
Nov 1, 2000